Recent Advances in Pathogenesis and Anticoagulation Treatment of Sepsis-Induced Coagulopathy
- PMID: 39845020
- PMCID: PMC11752821
- DOI: 10.2147/JIR.S495223
Recent Advances in Pathogenesis and Anticoagulation Treatment of Sepsis-Induced Coagulopathy
Abstract
Coagulopathy in sepsis is common and is associated with high mortality. Although immunothrombosis is necessary for infection control, excessive thrombus formation can trigger a systemic thrombo-inflammatory response. Immunothrombosis plays a core role in sepsis-induced coagulopathy, and research has revealed a complex interplay between inflammation and coagulation. Different mechanisms underlying sepsis-related coagulopathy are discussed, including factors contributing to the imbalance of pro- and anticoagulation relevant to endothelial cells. The potential therapeutic implications of anticoagulants on these mechanisms are discussed. This review contributes to our understanding of the pathogenesis of coagulopathy in patients with sepsis. Recent studies suggest that endothelial cells play an important role in immunoregulation and hemostasis. Meanwhile, the non-anticoagulation effects of anticoagulants, especially heparin, which act in the pathogenesis of coagulopathy in septic patients, have been partially revealed. We believe that further insights into the pathogenesis of sepsis-induced coagulopathy will help physicians evaluate patient conditions effectively, leading to advanced early recognition and better decision-making in the treatment of sepsis.
Keywords: anticoagulant; coagulopathy; endotheliopathy; immunothrombosis; sepsis; thromboinflammation.
© 2025 Man et al.
Conflict of interest statement
The authors declare that they have no competing interests in this work.
Figures

Similar articles
-
The role of thromboinflammation in acute kidney injury among patients with septic coagulopathy.J Thromb Haemost. 2024 Jun;22(6):1530-1540. doi: 10.1016/j.jtha.2024.02.006. Epub 2024 Feb 19. J Thromb Haemost. 2024. PMID: 38382739 Review.
-
Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation.J Thromb Haemost. 2023 Dec;21(12):3360-3370. doi: 10.1016/j.jtha.2023.05.028. Epub 2023 Sep 16. J Thromb Haemost. 2023. PMID: 37722532 Free PMC article.
-
Sepsis-Induced Coagulopathy: A Comprehensive Narrative Review of Pathophysiology, Clinical Presentation, Diagnosis, and Management Strategies.Anesth Analg. 2024 Apr 1;138(4):696-711. doi: 10.1213/ANE.0000000000006888. Epub 2024 Feb 7. Anesth Analg. 2024. PMID: 38324297 Free PMC article. Review.
-
Coagulopathy and COVID-19.Eur Heart J Suppl. 2021 Oct 8;23(Suppl E):E95-E98. doi: 10.1093/eurheartj/suab100. eCollection 2021 Oct. Eur Heart J Suppl. 2021. PMID: 34650364 Free PMC article.
-
Thromboinflammation in Sepsis and Heparin: A Review of Literature and Pathophysiology.In Vivo. 2022 Nov-Dec;36(6):2542-2557. doi: 10.21873/invivo.12991. In Vivo. 2022. PMID: 36309378 Free PMC article. Review.
Cited by
-
Anti-Thrombotic Activity of 3-Deoxysappanchalcone via Inhibiting Platelet Aggregation and Thrombin (FIIa)/Activated Factor X (FXa) Activity.Molecules. 2025 Jun 13;30(12):2580. doi: 10.3390/molecules30122580. Molecules. 2025. PMID: 40572543 Free PMC article.
-
An individualized nomogram for predicting risk of sepsis in patients with pyogenic liver abscesses: a 10 years retrospective analysis.Front Med (Lausanne). 2025 Jul 9;12:1555656. doi: 10.3389/fmed.2025.1555656. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40703270 Free PMC article.
-
Immunothrombosis in Sepsis: Cellular Crosstalk, Molecular Triggers, and Therapeutic Opportunities-A Review.Int J Mol Sci. 2025 Jun 25;26(13):6114. doi: 10.3390/ijms26136114. Int J Mol Sci. 2025. PMID: 40649892 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources